Navitor Pharmaceuticals is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways. The company’s proprietary drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth.

Biotechnology

Navitor Pharmaceuticals

Thomas E. Hughes

Jamie Mallon Palme

Seung Hahm, Ph.D.

James Randall Randy Owen

Eddine Saiah

Corporate Governance

Leadership Team

Research and Development

Teams at Navitor Pharmaceuticals

Corporate Governance

Leadership Team

Research and Development